Injectable and Topical Peptides in Aesthetic Medicine Mechanisms, Clinical Applications, and Future Potential PRIME Journal The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] Preprints.org FDA Removes 14 Peptides from Category 2 to Category 1 Mansi Hukmani posted on the topic LinkedIn